Abstract:Objective: To investigate the effects of Annexin A2 (ANXA2) deficiency on the malignant biological behaviour of hepatoma cells. Methods: The human hepatocellular carcinoma (HCC) cells lines MHCC97-H, HepG2, SMMC-7721, SMMC-7402 and L02 were evaluated. The expression and distribution of ANXA2 were analysed by western blotting, real-time PCR, immunofluorescence and immunohistochemistry.Cell cycle was assessed by flow cytometry and propidium iodide staining. Effects of ANXA2 silencing on invasion and migration potential were assessed by transwell assay and wound healing assay, respectively. Proliferative potential was assessed by CCK-8 kit in vitro and xenograft tumour-growth assay in vivo. The t-test, chi square test, rank sum test, q-test and F-test were used for statistical analyses. Results: The expression level of ANXA2 was markedly higher in the MHCC97-H cells with high metastasis potential than in the HepG2, SMMC-7721, SMMC-7402 and L02 cells. The efficiency of shRNA-mediated ANXA2 deficiency was more than 80%. Immunofluorescence analysis of the MHCC97-H cells indicated that ANXA2 expression was mainly localized to the cellular membrane and cytoplasm, with some nuclear localization. Down-regulation of ANXA2 led to S-phase arrest of HCC cells (q =8.001, P =0.002) and an inhibition of proliferation (q =17.140, P less than 0.01), migration (q =12.808, P less than 0.01) and invasion potential (q =9.069, P =0.002). Xenograft tumour-growth assay indicated that shRNA targeting of ANXA2 led to lower tumour weight (q =11.968, P < 0.001) and down-regulated ANXA2 expression (Z =2.530, P =0.011). Conclusion: Down-regulation of Annexin A2 gene transcription effectively changes the biological behaviours of hepatoma cells, and may represent a potential target of HCC molecular therapies.

[Effects of Annexin A2 gene transcription down-regulation on human hepatoma cell biological behaviour]

Effects of ANXA2 on Biological Behaviour of Human Hepotacellular Carcinoma in Vitro

Annexin A2 Enhances the Progression of Colorectal Cancer and Hepatocarcinoma via Cytoskeleton Structural Rearrangements

Annexin A2 Promotes the Migration and Invasion of Human Hepatocellular Carcinoma Cells in Vitro by Regulating the Shedding of CD147-Harboring Microvesicles from Tumor Cells

Annexin A2 knockdown inhibits hepatoma cell growth and sensitizes hepatoma cells to 5-fluorouracil by regulating β-catenin and cyclin D1 expression.

Effects of Annexin A2 on the Proliferation, Colony Formation and Cell Cycle of Human Breast Cancer Cell Line MDA-MB-231 and the Possible Molecular Mechanism

Annexin A7 suppresses lymph node metastasis of hepatocarcinoma cells in a mouse model

[Effects of Annexin II Gene Silencing by Sirna on Proliferation and Invasive Potential of Jurkat Lymphoma Cells].

Annexin II Promotes Invasion and Migration of Human Hepatocellular Carcinoma Cells in Vitro Via Its Interaction with HAb18G/CD147

ANXA2 enhances the progression of hepatocellular carcinoma via remodeling the cell motility associated structures

Upregulation Expressions and Clinical Significances of Annexin Ⅱ in Human Hepatocellular Carcinoma

Effects of ANXA4 on cell adhesive ability and expression of adhesion-related genes in hepatocellular carcinoma MHCC97H cell line

Annexin-1 Downregulation is Associated with Clinical Outcome in Chinese Patients with Hilar Cholangiocarcinoma

Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma

[Expression of Annexin I in Human Pancreatic Cancer and the Influence of Its Down-Regulation on Biology of This Cancer].

Effects of Annexin II Gene Silencing by SiRNA on Apoptosis of Lymphoma Cell Line Jurkat

Targeting of Annexin A1 in Tumor-Associated Macrophages As a Therapeutic Strategy for Hepatocellular Carcinoma

Apoptosis-inducing Effect of Annexin A2 on Multiple Myeloma Cells and Its Related Mechanisms

Clinical significance of Annexin A2 expression in oral squamous cell carcinoma and its influence on cell proliferation, migration and invasion

The effects of ANXA2 expression level on the proliferation and motility of Caco-2 Cells

Increased expression of Annexin A2 in oral squamous cell carcinoma.